Parkinson's Disease Clinical Trial
Official title:
Postural Instability in Progressive Supranuclear Palsy: Why do Patients With PSP Fall?
NCT number | NCT01563276 |
Other study ID # | IRB00007924 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | December 2011 |
Est. completion date | May 10, 2013 |
Verified date | September 2019 |
Source | Oregon Health and Science University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to better understand why individuals with Progressive
Supranuclear Palsy (PSP) fall. Understanding the mechanism of gait and balance dysfunction in
individuals with PSP may provide us with important early diagnostic tools, allowing for
earlier identification of mobility problems and to better evaluate medical therapies aimed at
improving motor disability.
The investigators will recruit 10 PSP, 10 PD and 10 healthy controls for the study. All
subjects will be asked to come to the OHSU clinic at the Center for Health and Healing for an
initial screening visit. They will meet with the primary investigator to conduct a brief
interview and physical examination. In addition, they will be asked to answer questions
regarding current and past medical illness, how often they fall and what kinds of medications
they are on.
Subjects who agree to participate will come to the Oregon Clinical and Translational Research
Institute (OCTRI) at OHSU for balance testing. Subjects will be asked to stand or sit on a
movable platform with eyes open or closed. Prior to standing on the platform, the
investigators will place 6 small sensors on body which are held in place by velcro straps
(one on each wrist, ankles, chest and lower back). The platform will then be moved (tilt or
slide) while subjects try to keep their balance. During all of the balance tests described
above, body movements will be recorded from the sensors on the subjects' body. This data is
directly recorded by a computer and analyzed to help us gain better understanding of the
subjects' posture and their ability to remain up right.
Status | Completed |
Enrollment | 36 |
Est. completion date | May 10, 2013 |
Est. primary completion date | May 10, 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 85 Years |
Eligibility |
Inclusion Criteria: 1. Diagnosis of probable or possible PSP as defined by the National Institute of Neurological Disorders and Stroke and Society for Progressive Supranuclear Palsy (NINDS-SPSP) diagnostic criteria. 2. Be able to ambulate and stand unassisted for 5 minutes 3. Be able to cooperate with gait and balance testing 4. Be able to give informed consent. Exclusion Criteria: 1. Cannot exhibit behavior or have dementia that precludes participation in the protocol 2. Cannot have medical or orthopedic illness that, in the investigator's opinion, would impact the patient's postural control or ability to participate in the study. |
Country | Name | City | State |
---|---|---|---|
United States | Oregon Health and Science University | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Relative contributions of vestibular and visual information to postural control in PSP | To gage the relative contributions of vestibular and visual information to postural control in PSP we will measure body sway using two different tests (LOS and SOT) while a patient stands on a movable force plate within a movable visual surround. | Single visit. 2 hours. | |
Secondary | Postural Response Latencies | Subjects will stand on a movable platform with a movable visual surround. Subjects will be asked to keep their balance while the platform is translated or roated. | Single visit. 2 hours. | |
Secondary | Gait patterns and postural transitions | Subjects will be asked to rise from a chair, walk and turn. Ambulatory balance will be measured by a time up and go test (TUG). Six accelerometers will be placed on the subject and will measure parameters including arm swing, number of steps and turn duration. | Single visit. 10 minutes. | |
Secondary | Perception of vertical and horizontal references | Subjects will perform two different tasks with their eyes closed while standing and sitting on a force plate that is tilting in the antero-posterior direction. They will perform the following two tasks: 1. Hold a rod parallel to the gravitional vertical 2. Hold a rod perpendicular to the tilting surface so it remains 90 degrees to the surface at all times. Six accelerometers will measure lower and upper body tilt. | Single visit. 2 hours. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Terminated |
NCT02924194 -
Deep Brain Stimulation of the nbM to Treat Mild Cognitive Impairment in Parkinson's Disease
|
N/A |